SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

MDxHealth SA (MDXH) News

Follow MDxHealth SA (MDXH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MDXH Asset equity Sector Markets 90 days 1 Last 0.1393 Updated Oct 15, 2026, 08:18 PM UTC Open live news feed Open MDXH chart & news
M MDxHealth Suspends Full-Year 2026 Revenue Guidance MDxHealth suspended its full-year 2026 revenue guidance. The company also announced preliminary third-quarter revenue, but the available text provides no figure. EQUITY | Oct 15, 2026, 08:18 PM UTC L MDxHealth sees return to positive EBITDA, reaffirms 2026 sales guidance MDxHealth said it expects tissue growth to accelerate in the second half and to return to positive adjusted EBITDA as it exits 2026, while reaffirming fiscal 2026 sales guidance of $110 million-$115 million. EARNINGS | Aug 14, 2026, 06:07 PM UTC L University of Michigan sentiment falls to 51 in early August The University of Michigan's consumer sentiment index declined to 51 in early August from 55.2 in the previous month, missing market estimates of 54.5. EARNINGS | Aug 14, 2026, 04:02 PM UTC L MDxHealth reports Q2 revenue growth, raises $20 million MDxHealth said Q2 2026 revenue was $27.2 million, up 16% year over year and 14% sequentially, while adjusted EBITDA was negative $2.3 million and it raised $20 million in a registered direct placement. EARNINGS | Aug 13, 2026, 09:14 PM UTC L MDxHealth shares rise on better-than-expected Q2 sales, FY26 guidance MDxHealth shares trade higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance above estimates. EARNINGS | Aug 13, 2026, 08:32 PM UTC L MDxHealth affirms FY2026 sales guidance at $110.0M–$115.0M MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate. EARNINGS | Aug 13, 2026, 08:13 PM UTC L MDXH reports second-quarter 2026 financial results Mdxhealth (MDXH) reports its second-quarter 2026 financial results, according to TradeXchange Newsdesk, with no additional figures provided in the feed. EARNINGS | Aug 13, 2026, 08:00 PM UTC L MDXH - Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 MDXH - Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 EARNINGS | Jul 30, 2026, 08:00 PM UTC L MDxHealth Gets Nasdaq Non-Compliance Notice () -- MDxHealth (MDXH) has received a notice from Nasdaq for failing to comply with its minimum bid price listing rule, the company said Thursday. The company has until Dec. 28 to regain compliance. Copyright © 2026. All EQUITY | Jul 02, 2026, 08:12 PM UTC L Mdxhealth Receives Nasdaq Noncompliance Notice, Gets Time Through Dec. 28 To Regain Compliance Mdxhealth SA (NASDAQ: MDXH ) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the "Notification Letter") from the Listing EQUITY | Jul 02, 2026, 08:01 PM UTC